Product Information
REFRESH RELIEVA 0.5-0.9% DROP is a brand product labeled by Allergan, Inc., priced at $1.0887 per ML under NDC 00023663010. Its NADAC has been published 107 times since Sep 18, 2024.
Strength
5; 9 mg/mL; mg/mL
Manufacturer
Allergan, Inc.NDC
00023663010
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
5/20/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUM; GLYCERINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
7/22/2019
Pharmacological Classes
Price Statistics
The NADAC for REFRESH RELIEVA 0.5-0.9% DROP has been published 107 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0887 per ML |
|---|---|
| All-time high | $1.0888 (Sep 10, 2025) |
| All-time low | $1.0878 (Mar 18, 2026) |
| 52-week high | $1.0888 |
| 52-week low | $1.0878 |
| Median price | $1.0883 |
| Average price | $1.0884 |
| Largest weekly change | +0.1% (May 20, 2026) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Carboxymethylcellulose sodium, Glycerin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carboxymethylcellulose sodium, Glycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH RELIEVA 0.5-0.9% DROP?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH RELIEVA 0.5-0.9% DROP, manufactured by Allergan, Inc., is $1.0887 per ML (NDC 00023663010), effective Sep 30, 2026.
How has the price of REFRESH RELIEVA 0.5-0.9% DROP changed over time?
Over the history we have for it, the NADAC for REFRESH RELIEVA 0.5-0.9% DROP has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for REFRESH RELIEVA 0.5-0.9% DROP?
Since Sep 18, 2024, the NADAC for REFRESH RELIEVA 0.5-0.9% DROP has ranged from a low of $1.0878 (Mar 18, 2026) to a high of $1.0888 (Sep 10, 2025), with a median of $1.0883 per ML.
Are there cheaper alternatives to REFRESH RELIEVA 0.5-0.9% DROP?
No other NADAC-published product currently shares the active ingredient and strength of REFRESH RELIEVA 0.5-0.9% DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REFRESH RELIEVA 0.5-0.9% DROP?
REFRESH RELIEVA 0.5-0.9% DROP (NDC 00023663010) is labeled by Allergan, Inc., and CMS classifies it as a brand product.